KR950032111A - 당 알콜의 신규한 황산 에스테르 - Google Patents

당 알콜의 신규한 황산 에스테르 Download PDF

Info

Publication number
KR950032111A
KR950032111A KR1019950000506A KR19950000506A KR950032111A KR 950032111 A KR950032111 A KR 950032111A KR 1019950000506 A KR1019950000506 A KR 1019950000506A KR 19950000506 A KR19950000506 A KR 19950000506A KR 950032111 A KR950032111 A KR 950032111A
Authority
KR
South Korea
Prior art keywords
sulfo
penta
sodium salt
bis
glucit
Prior art date
Application number
KR1019950000506A
Other languages
English (en)
Inventor
슈콜로프스키 알렉산더
핑게를 위르겐
이베르크 니기
페터 메르키 한스
뮐러 리타
페흐 미카엘
루우즈 마리안네
슈미트 제라르
쵸프 토마스
페터 베셀 한스
Original Assignee
프리돌린 클라우스너, 롤란드 보러
에프. 호프만-라 롯슈 아크티엔게젤샤프트
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 프리돌린 클라우스너, 롤란드 보러, 에프. 호프만-라 롯슈 아크티엔게젤샤프트 filed Critical 프리돌린 클라우스너, 롤란드 보러
Publication of KR950032111A publication Critical patent/KR950032111A/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/57—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C323/58—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups with amino groups bound to the carbon skeleton
    • C07C323/59—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups with amino groups bound to the carbon skeleton with acylated amino groups bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C305/00—Esters of sulfuric acids
    • C07C305/02—Esters of sulfuric acids having oxygen atoms of sulfate groups bound to acyclic carbon atoms of a carbon skeleton
    • C07C305/04—Esters of sulfuric acids having oxygen atoms of sulfate groups bound to acyclic carbon atoms of a carbon skeleton being acyclic and saturated
    • C07C305/10—Esters of sulfuric acids having oxygen atoms of sulfate groups bound to acyclic carbon atoms of a carbon skeleton being acyclic and saturated being further substituted by singly-bound oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C305/00—Esters of sulfuric acids
    • C07C305/02—Esters of sulfuric acids having oxygen atoms of sulfate groups bound to acyclic carbon atoms of a carbon skeleton
    • C07C305/04—Esters of sulfuric acids having oxygen atoms of sulfate groups bound to acyclic carbon atoms of a carbon skeleton being acyclic and saturated
    • C07C305/06—Hydrogenosulfates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C311/16—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
    • C07C311/17—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/16—Sulfones; Sulfoxides having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C317/22—Sulfones; Sulfoxides having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/26—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C317/32—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • C07C317/34—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having sulfone or sulfoxide groups and amino groups bound to carbon atoms of six-membered aromatic rings being part of the same non-condensed ring or of a condensed ring system containing that ring
    • C07C317/36—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having sulfone or sulfoxide groups and amino groups bound to carbon atoms of six-membered aromatic rings being part of the same non-condensed ring or of a condensed ring system containing that ring with the nitrogen atoms of the amino groups bound to hydrogen atoms or to carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C335/00—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C335/04—Derivatives of thiourea
    • C07C335/16—Derivatives of thiourea having nitrogen atoms of thiourea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • C07D311/80—Dibenzopyrans; Hydrogenated dibenzopyrans
    • C07D311/82—Xanthenes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Vascular Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Steroid Compounds (AREA)
  • Laser Surgery Devices (AREA)
  • Seasonings (AREA)

Abstract

본 발명은 하기 일반식 ( I ) 의 당 알콜 및 당 알콜-유사 화합물 및 그의 염의 신규한 황산 에스테르에 관한 것이다.
상기식에서, A는 하나 이상의 하이드록시 그룹이 황산으로 에스테르화된, 1-하이드록시 그룹이 없는 당 알콜 또는 이들의 유도체의 잔기이거나 또는 트리스-(하이드록시메틸)메틸 잔기이고; X는 -NR1CO-, -NHCONH-, -NHCSNH-, -NHSO2-, -NR1또는 -O-이고; m 및 p는 각각 독립적으로 O 또는 1이고; R1은 수소, 저급-알킬 또는 하이드록시-저급-알킬이며; B는 공액화된 다중 결합 시스템이다.
또한 본 발명은 일반식 (I)의 화합물 또는 그의 염을 함유하는 약학 제제; 특히 혈관 벽에서의 동맥경화성변화의 치료 및/또는 예방(예 : 관상 또는 말단 혈관성형술 또는 보조 수술 후의 재발협착증의 예방)을 위한 약제로서의 일반식 (I)의 화합물 및 그의 염의 용도; 일반식 (I )의 화합물 및 그의 염의 제조 방법 뿐만 아니라 상기 징후를 위한 약제의 제조에 관한 것이다.

Description

당 알콜의 신규한 황산 에스테르
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (10)

  1. 하기 일반식 (I)의 화합물 및 그의 염 :
    상기식에서, A는 하나 이상의 하이드록시 그룹이 황산으로 에스테르화된, 1-하이드록시 그룹이 없는 당 알콜 또는 이들의 유도체의 잔기이거나 또는 트리스-(하이드록시메틸)메틸 잔기이고; X는 -NR1CO-, -NHCONH-, -NHCSNH-, -NHSO2-, -NR1또는 -O-이고; m 및 p는 각각 독립적으로 0 또는 1이고; R1은 수소, 저급-알킬 또는 하이드록시-저급-알킬이며; B는 공액화된 다중 결합 시스템이다.
  2. 제1항에 있어서, X가 -NR1CO-, -NHCONH-, -NHCSNH-, -NHSO2-또는 -O-이고; B가 공액화된 이중 결합 시스템인 화합물 및 그의 염.
  3. 제1항에 있어서, A가 -(CHR2)nCH2R2이고, n은 1 내지 5의 정수이고, R2는 H, -OSO3H 또는 OZ이고, Z가 보호그룹이고, 적어도 하나의 잔기 R2가 -OSO3H인 화합물.
  4. 제1항 내지 제3항 중 어느 한 항에 있어서, 상기 공액화된 다중 결합 시스템 B가 2 내지 8개의 공액화된 다중 결합을 지닌 폴리엔 또는 폴리린 탄화수소 잔기인 화합물.
  5. 제1항 내지 제4항 중 어느 한 항에 있어서, 상기 공액화된 다중 결합 시스템 B가 공액화된 이중 결합의 시스템인 화합물.
  6. 제5항에 있어서, 상기 공액화된 이중 결합 시스템이 방향족 고리 시스템인 화합물.
  7. 제6항에 있어서, 상기 방향족 고리 시스템이 페닐렌; 저급-알킬 치환된 페닐렌; 나프틸렌, 플루오레닐렌; 또는 하기 일반식 (a) 내지 (s)중 하나의 잔기인 화합물 :
    상기식에서, Y는 탄소-탄소 결합, -O-, -CO-, -CH2-, -CH2-CH2-, -C≡C-, -CH(O)CH-, -CH=CH-, -SO2-, -C(CF3)2-, -CONR1-, -NHC0NH-, -NHCOCONH-, 페닐렌 또는 페닐렌디옥시이고; R1은 수소, 저급-알킬 또는 하이드록시-저급-알킬이고; R3및 R4는 수소, 저급-알킬, 저급-알콕시, 할로겐 또는 -SO3H이고; R5는 저급-알콕시-저급-알콕시, 페녹시 또는 할로겐에 의해 치환된 페녹시이고; R6은 수소 또는 SO5H이고; D는 -CH2CH2- 또는 -CH=CH-이며; V는 -CH=CH-, -CH2CH2- 또는 단일 결합을 의미한다.
  8. (Z)-부텐디오산(Z)-〔3-비페닐-4-일옥시메틸-5-〔3-(2,3,4,5,6-펜타-O-설포-D-글루시트-1-일카바모일)-아크릴로일아미노〕-페닐아미드〕-(2,3,4,5,6-펜타-O-설포-D-글루시트-1-일)-아미드 10나트륨 염, (E)-2-클로로스틸벤-4,4′-디카복실산 비스-(2,3,4,5,6-펜타-O-설포-D-글루시트-1-일아미드) 10나트륨 염, (Z)-스틸벤-4,4′-디카복실산 비스-(2,3,4,5,6-펜타-O-설포-D-글루시트-1-일아미드) 10나트륨 염,(2E,4E,6E,8E,1OE,12E,14E)-2,6,11,15-테트라메틸-헥사데카-2,4,6,8,10,12,14-헵타엔디카복실산 비스-(2,3,4,5,6-펜타-O-설포-D-글루시트-1-일아미드) 1O나트륨 염,4,4′-에틸렌-디벤조산 비스-(2,3,4,5,6-펜타-O-설포-D-글루시트-1-일아미드) 1O 나트륨 염, 3,3′-비스-(2,3,4,5,6-펜타-O-설포-D-글루시트-1-일)-1,1′-톨루엔-2,6-디일)-디우레아 1O 나트륨 염, 4,4′-비스-(2,3,4,5,6-펜타-O-설포-D-글루시트-1-일아미노)-3,3′-디니트로-N,N′-(4,4′-메틸렌-디페닐)-디벤즈아미드 10나트륨 염. N,N′-비스-(2,3,4,5,6-펜타-O-설포-D-글루시트-l-일)-2,2′-디니트로-4,4′-설포닐디아닐린 10나트륨 염, (Z)-스틸벤-4,4′-디카복실산 비스-(2,3,4,5,6-펜타-O-설포-L-람니트-1-일아미드) 8나트륨 염, 나프탈렌-1,5-디설폰산 비스-(2,3,4,5, 6-펜타-0-설포-D-글루시트-1-일아미드) 1O 나트륨 염, N,N′-비스-〔4-(2,3,4,5-테트라-O-설포-D-아라비니트-1-일옥시)-페닐〕-이소프탈아미드 8나트륨 염, 1,3-비스- 〔4-〔2,3,4,5,6-펜타-O-설포-D-갈락티트-6-일옥시)-페닐〕-우레아 10나트륨 염, N,N′-비스-〔4-〔3-(2,3,4,5,6-펜타-O-설포-D-글루시트-1-일)-우레이도〕-페닐〕-이소프탈아미드 10나트륨 염, 9-옥소-9H-플루오렌-2,7-디카복실산 비스-〔메틸-(2,3,4,5,6-펜타-O-설포-D-글루시트-1-일)아미드〕 10나트륨 염, 4,4′-메틸렌-디벤조산 비스-(2,3,4,5,6-펜타-O-설포-D-글루시트-1-일아미드) 10나트륨 염, 나프탈렌-2,6-디카복실산 비스-(2,3.4,5,6-펜타-O-설포-D-글루시트-1-일아미드) 10나트륨 염, N.N′-비스-(2,3,4,5,6-펜타-O-설포-D-글루시트-1-일)-이소프탈아미드 10나트륨 염, N,N′-비스-〔4-〔3-(2,3,4,5,6-펜타-O-설포-D-글루시트-1-일)-우레이도〕-페닐〕-푸마르아미드 1O나트륨 염, 4,4′-설포닐-디벤조산 비스-(2,3,4,5,6-펜타 -O-설포-D-글루시트-1-일아미드) 10나트륨 염.
  9. 특히 혈관벽중 동맥경화성 변화의 치료 및/또는 예방을 위한, 제1항 내지 제8항 중 어느 한 항에 따른 화합물, 및 치료적으로 불활성인 담체를 함유하는 약제.
  10. 제1항 내지 제8항 중 어느 한 항에 따른 화합물의 상응하는 비-황산화된 화합물을 황산화제와 반응시킴을 포함하는 제1항 내지 제8항 중 어느 한 항에 따른 화합물의 제조 방법.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019950000506A 1994-01-14 1995-01-13 당 알콜의 신규한 황산 에스테르 KR950032111A (ko)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CH114/94 1994-01-14
CH11494 1994-01-14
CH3315/94 1994-11-07
CH331594 1994-11-07

Publications (1)

Publication Number Publication Date
KR950032111A true KR950032111A (ko) 1995-12-20

Family

ID=25683559

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019950000506A KR950032111A (ko) 1994-01-14 1995-01-13 당 알콜의 신규한 황산 에스테르

Country Status (21)

Country Link
US (1) US5521160A (ko)
EP (1) EP0663391B1 (ko)
JP (1) JP2862489B2 (ko)
KR (1) KR950032111A (ko)
CN (1) CN1043349C (ko)
AT (1) ATE151416T1 (ko)
AU (1) AU685196B2 (ko)
CA (1) CA2139720A1 (ko)
CZ (1) CZ8395A3 (ko)
DE (1) DE59500162D1 (ko)
DK (1) DK0663391T3 (ko)
ES (1) ES2101583T3 (ko)
FI (1) FI950127A (ko)
GR (1) GR3024012T3 (ko)
HU (1) HUT72412A (ko)
IL (1) IL112284A (ko)
NO (1) NO302817B1 (ko)
NZ (1) NZ270316A (ko)
RU (1) RU2139854C1 (ko)
TW (1) TW308598B (ko)
UA (1) UA42696C2 (ko)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2174582A1 (en) * 1995-05-05 1996-11-06 Alexander Chucholowski Sulphuric acid esters of amino-sugars
CA2174583A1 (en) * 1995-05-05 1996-11-06 Alexander Chucholowski Sulfuric acid esters of sugar alcohols
US7105552B2 (en) * 1998-05-08 2006-09-12 Theracos, Inc. Heterocyclic analogs of diphenylethylene compounds
US6245814B1 (en) 1998-05-08 2001-06-12 Calyx Therapeutics, Inc. Diphenylethylene compounds
US6331633B1 (en) 1998-05-08 2001-12-18 Calyx Therapeutics Inc. Heterocyclic analogs of diphenylethylene compounds
US6624197B1 (en) 1998-05-08 2003-09-23 Calyx Therapeutics, Inc. Diphenylethylene compounds
AU769489B2 (en) * 1998-09-11 2004-01-29 Ilexus Pty Limited Fc receptor modulators and uses thereof
US7407978B2 (en) * 1999-04-06 2008-08-05 Theracos, Inc. Heterocyclic analogs of diphenylethylene compounds
US20020002200A1 (en) * 2000-02-04 2002-01-03 Bishwagit Nag Novel diphenylethylene compounds
US20080108825A1 (en) * 1999-11-08 2008-05-08 Theracos, Inc. Compounds for treatment of inflammation, diabetes and related disorders
US7323496B2 (en) * 1999-11-08 2008-01-29 Theracos, Inc. Compounds for treatment of inflammation, diabetes and related disorders
US6525093B1 (en) * 1999-11-08 2003-02-25 Calyx Therapeutics Inc. Compounds to treat diabetes and associated conditions
US20080103302A1 (en) * 2000-02-04 2008-05-01 Theracos, Inc. Compounds for treatment of inflammation, diabetes and related disorders
US6635786B2 (en) * 2001-01-16 2003-10-21 Guilford Pharmaceuticals, Inc. Symmetrically disubstituted aromatic compounds and pharmaceutical compositions for inhibiting poly (ADP-ribose) glycohydrolase, and methods for their use
GB0228410D0 (en) 2002-12-05 2003-01-08 Glaxo Group Ltd Novel Compounds
CN1318479C (zh) * 2002-12-11 2007-05-30 日产化学工业株式会社 新颖的二氨基苯衍生物、使用了该衍生物的聚酰亚胺前体和聚酰亚胺及液晶定向处理剂
JP6051998B2 (ja) 2012-03-30 2016-12-27 日油株式会社 マルチアーム型ポリエチレングリコール誘導体、その中間体及び製造方法
CN104768549A (zh) * 2012-05-22 2015-07-08 耶路撒冷希伯来大学的益生研究开发有限公司 未分化细胞的选择性抑制剂
CN110092737B (zh) * 2018-01-31 2022-06-17 海思美域(深圳)科技有限公司 一种抗静电化合物、材料的表面处理方法及改性材料

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3734815A1 (de) * 1987-10-14 1989-04-27 Luitpold Werk Chem Pharm Polyschwefelsaeureester von bis-aldonsaeureamiden und deren derivaten, verfahren zu ihrer herstellung und arzneimittel
DE3734853A1 (de) * 1987-10-14 1989-04-27 Luitpold Werk Chem Pharm Bis-aldonsaeureamide und verfahren zu ihrer herstellung
US5298616A (en) * 1990-10-03 1994-03-29 Hoffmann-La Roche Inc. Sulfated O-polysaccharide-trehaloses
CA2061370A1 (en) * 1991-03-13 1992-09-14 Markus Hosang Pharmaceutical preparations

Also Published As

Publication number Publication date
NO950137D0 (no) 1995-01-13
US5521160A (en) 1996-05-28
CZ8395A3 (en) 1995-11-15
FI950127A0 (fi) 1995-01-11
IL112284A (en) 1998-10-30
TW308598B (ko) 1997-06-21
EP0663391B1 (de) 1997-04-09
JP2862489B2 (ja) 1999-03-03
NO950137L (no) 1995-07-17
CA2139720A1 (en) 1995-07-15
CN1043349C (zh) 1999-05-12
RU95100773A (ru) 1996-10-27
DK0663391T3 (da) 1997-10-20
RU2139854C1 (ru) 1999-10-20
GR3024012T3 (en) 1997-10-31
FI950127A (fi) 1995-07-15
AU1010695A (en) 1995-07-27
ATE151416T1 (de) 1997-04-15
UA42696C2 (uk) 2001-11-15
EP0663391A1 (de) 1995-07-19
HUT72412A (en) 1996-04-29
AU685196B2 (en) 1998-01-15
ES2101583T3 (es) 1997-07-01
NZ270316A (en) 1996-08-27
NO302817B1 (no) 1998-04-27
DE59500162D1 (de) 1997-05-15
JPH07206803A (ja) 1995-08-08
CN1109889A (zh) 1995-10-11
IL112284A0 (en) 1995-03-30

Similar Documents

Publication Publication Date Title
KR950032111A (ko) 당 알콜의 신규한 황산 에스테르
CA1291165C (en) Alkylsulfonamidophenylalkylamines
US4065584A (en) Sulphur containing arylamine derivatives
US4252984A (en) Phenol ethers
GB2441032A (en) Salts of perfluorinated sulfoacetic acids
EP0657422B1 (en) Naphthyloxyacetic acid derivatives as PGE2 agonists and antagonists
ES541557A0 (es) Un procedimiento para la preparacion de nuevos derivados de 8-cloro-1,5-benzotiazepina
HU9400466D0 (en) Substituted benzoyl-guanidine derivatives, process for producing them, use of them for inhibiting cellular na+/h+ exchange and pharmaceutical and diagnostical compositions containing them
EP0353448B1 (de) Sulfonamide, Verfahren zu ihrer Herstellung sowie diese Verbindungen enthaltende Arzneimittel
SU510999A3 (ru) Способ получени (метоксиметил-фурилметил)6,7-бензоморфанов илиморфинанов
KR950008501A (ko) 3-아릴벤조푸라논의 제조방법
UA44238C2 (uk) Ортозаміщені похідні бензойної кислоти, спосіб їх одержання (варіанти), спосіб одержання фармацевтичної композиції
BG62067B2 (bg) Нови естери на сулфонови киселини с хидроксикумарини,метод за получаването им и лекарствени средства,които ги съдържат
US2774770A (en) Sulfur-containing amines
US4429162A (en) Perfluoroalkyl phenols and naphthols
KR910004547A (ko) 아미노프로판올 유도체와 그의 제조방법 및 그를 함유하는 약제조성물
CA2030004A1 (en) Tetrahydronaphthalene derivatives and preparation thereof
FI73206B (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara alkyltiofenoxipropylaminer.
US3878212A (en) Blood sugar lowering sulfamoyl pyrimidines and asymmetrical carbon atom
Bartmann et al. Convenient two-step stereospecific hydroxy-substitution with retention in β-hydroxy-δ-lactones. 4 (R)-heterosubstituted mevinolin and-analogs
US4975460A (en) Indanoxyacetic acid derivatives
JPH07215929A (ja) ナフチルオキシ酢酸誘導体およびそれらを有効成分として含有する薬剤
GB2062622A (en) Aniline Derivatives
US3531522A (en) 4'-phenoxyalkanesulfonanilides
US3702850A (en) 1,2,3,6-tetrahydropyridine derivatives

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E601 Decision to refuse application